Ancient Fables for the Neobiological Age
By Brian Bergstein,
Neo.Life
| 12. 28. 2017
What “Frankenstein” and the golem tell us about the power and responsibility of science.
January 1 marks the 200th anniversary of the publication of Frankenstein, Mary Shelley’s remarkable novel about a scientist who cobbles together body parts and brings them to life in a “new species.” Because Victor Frankenstein’s project has terrible unintended consequences — he ditches his monster because it is ugly, and the creature roams the world in a destructive search for a mate — the novel can be read as a warning about messing with nature. Those sad and scary themes rear up when people use a term like “Frankenfoods” to denigrate bioengineered products.
But even if Shelley thought of the book as cautionary tale (and it’s debatablewhether she did), that isn’t a very useful cultural shorthand today, as we wrestle with the implications of gene editing, gene writing, and other technologies that give us more power than ever to manipulate biology. Caution is of course required with these technologies. But an excess of it—too much worry about unleashing Frankenstein’s monster—could be even more dangerous. Ultimately, we’re going to have...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...